MedPath
NMPA Approval

Compound Troxerutin and Poreine Cerebroside Injection

国药准字H22026579

August 10, 2020

Drug Information

复方曲肽注射液

天成

注射剂

2ml:80mg曲克芦丁,1.0mg总氮,0.6mg单唾液酸四己糖神经节苷脂(GM1)

化学药品

August 10, 2020

Company Information

Applicant Company

吉林省梅河口市建国路4555号

Manufacturing Company

吉林省梅河口市建国路4555号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方曲肽注射液 - NMPA 批准文号 | MedPath